PL
PL · PL · PL-100338990
Xydalba
ATC J01XA04
Last synced from URPL (Poland) on
Identification
ManufacturerAbbVie Deutschland GmbH & Co. KG
CountryPL (PL)
ATC codeJ01XA04
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 2
- gtin05016007206036
- gtin08718868711007
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Proszek do sporządzania koncentratu roztworu do infuzji",
"source": "urpl",
"strength": "500 mg",
"packaging": "05016007206036 ¦ Rp ¦ EU/1/14/986/001 ¦ 107410\n1 fiol. \n08718868711007 ¦ Rp ¦ Skasowane ¦ EU/1/14/986/001 ¦ 130933\n1 fiol.",
"substance": "Dalbavancinum 500 mg",
"common_name": "Dalbavancinum",
"pl_product_id": "100338990",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code J01XA04.
- 🇺🇸DalbavancinLong Grove Pharmaceuticals, LLC
- 🇺🇸DalbavancinTeva Pharmaceuticals, Inc.
- 🇺🇸DalbavancinMeitheal Pharmaceuticals Inc
- DKDalbavancin "Adalvo"AdAlvo Limited
- DKDalbavancin "Baxter"Baxter Holding B.V.
- DKDalbavancin "Teva"Teva B.V.
- DKDalbavancin "Tillomed"Tillomed Malta Limited
- GBDalbavancin 500mg powder for concentrate for solution for infusion vialsAccord-UK Ltd
Access this data programmatically
Query Xydalba and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.